| Report ID |
225228 |
| Drug Identification Number |
02355183 |
| Brand name |
CISPLATIN INJECTION, BP |
| Common or Proper name |
CISPLATIN |
| Company Name |
ACCORD HEALTHCARE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
CISPLATIN |
| Strength(s) |
1MG |
| Dosage form(s) |
SOLUTION |
| Route of administration |
INTRAVENOUS
INTRAVENOUS |
| Packaging size |
50ML |
| ATC code |
L01XA |
| ATC description |
OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage |
Requirements related to complying with good manufacturing practices. |
| Anticipated start date |
|
| Actual start date |
2024-06-18 |
| Estimated end date |
2024-10-25 |
| Actual end date |
2024-10-25 |
| Shortage status |
Resolved |
| Updated date |
2024-10-26 |
| Company comments |
|
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
